These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 14707728)

  • 1. Tumor-stroma interaction of human pancreatic cancer: acquired resistance to anticancer drugs and proliferation regulation is dependent on extracellular matrix proteins.
    Miyamoto H; Murakami T; Tsuchida K; Sugino H; Miyake H; Tashiro S
    Pancreas; 2004 Jan; 28(1):38-44. PubMed ID: 14707728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokines modulate MIA PaCa 2 and CAPAN-1 adhesion to extracellular matrix proteins.
    Stefani AL; Basso D; Panozzo MP; Greco E; Mazza S; Zancanaro F; De Franchis G; Plebani M
    Pancreas; 1999 Nov; 19(4):362-9. PubMed ID: 10547196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The extracellular matrix differentially regulates the expression of PTHrP and the PTH/PTHrP receptor in FG pancreatic cancer cells.
    Grzesiak JJ; Clopton P; Chalberg C; Smith K; Burton DW; Silletti S; Moossa AR; Deftos LJ; Bouvet M
    Pancreas; 2004 Aug; 29(2):85-92. PubMed ID: 15257098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracellular matrix proteins protect pancreatic cancer cells from death via mitochondrial and nonmitochondrial pathways.
    Vaquero EC; Edderkaoui M; Nam KJ; Gukovsky I; Pandol SJ; Gukovskaya AS
    Gastroenterology; 2003 Oct; 125(4):1188-202. PubMed ID: 14517801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human ductal adenocarcinomas of the pancreas express extracellular matrix proteins.
    Löhr M; Trautmann B; Göttler M; Peters S; Zauner I; Maillet B; Klöppel G
    Br J Cancer; 1994 Jan; 69(1):144-51. PubMed ID: 8286197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of Tumor Microenvironment in Chemoresistance: 3D Extracellular Matrices as Accomplices.
    Senthebane DA; Jonker T; Rowe A; Thomford NE; Munro D; Dandara C; Wonkam A; Govender D; Calder B; Soares NC; Blackburn JM; Parker MI; Dzobo K
    Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30241395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment of gemcitabine-resistant human pancreatic cancer cells and effect of brefeldin-a on the resistant cell line.
    Togawa A; Ito H; Kimura F; Shimizu H; Ohtsuka M; Shimamura F; Yoshidome H; Katoh A; Miyazaki M
    Pancreas; 2003 Oct; 27(3):220-4. PubMed ID: 14508125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alteration of integrins by interleukin-1alpha in human pancreatic cancer cells.
    Sawai H; Yamamoto M; Okada Y; Sato M; Akamo Y; Takeyama H; Manabe T
    Pancreas; 2001 Nov; 23(4):399-405. PubMed ID: 11668210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promotion of tumor cell migration by extracellular matrix proteins in human pancreatic cancer.
    Ryschich E; Khamidjanov A; Kerkadze V; Büchler MW; Zöller M; Schmidt J
    Pancreas; 2009 Oct; 38(7):804-10. PubMed ID: 19893454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of multidrug resistance-associated protein 2 is involved in chemotherapy resistance in human pancreatic cancer.
    Noma B; Sasaki T; Fujimoto Y; Serikawa M; Kobayashi K; Inoue M; Itsuki H; Kamigaki M; Minami T; Chayama K
    Int J Oncol; 2008 Dec; 33(6):1187-94. PubMed ID: 19020751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Breast Cancer Resistance Protein Expression on the In Vitro Efficacy of Anticancer Drugs in Pancreatic Cancer Cell Lines.
    Washio I; Nakanishi T; Ishiguro N; Yamamura N; Tamai I
    Drug Metab Dispos; 2018 Mar; 46(3):214-222. PubMed ID: 29246888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemoresistance Transmission via Exosome-Mediated EphA2 Transfer in Pancreatic Cancer.
    Fan J; Wei Q; Koay EJ; Liu Y; Ning B; Bernard PW; Zhang N; Han H; Katz MH; Zhao Z; Hu Y
    Theranostics; 2018; 8(21):5986-5994. PubMed ID: 30613276
    [No Abstract]   [Full Text] [Related]  

  • 13. Nerve growth factor exerts differential effects on the growth of human pancreatic cancer cells.
    Zhu ZW; Friess H; Wang L; Bogardus T; Korc M; Kleeff J; Büchler MW
    Clin Cancer Res; 2001 Jan; 7(1):105-12. PubMed ID: 11205897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycosaminoglycans modulate C6 glioma cell adhesion to extracellular matrix components and alter cell proliferation and cell migration.
    Aguiar CB; Lobão-Soares B; Alvarez-Silva M; Trentin AG
    BMC Cell Biol; 2005 Aug; 6():31. PubMed ID: 16111491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression Changes and Impact of the Extracellular Matrix on Etoposide Resistant Human Retinoblastoma Cell Lines.
    Reinhard J; Wagner N; Krämer MM; Jarocki M; Joachim SC; Dick HB; Faissner A; Kakkassery V
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32560557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of adenovirus expressing wild-type p53 on 5-fluorouracil chemosensitivity is related to p53 status in pancreatic cancer cell lines.
    Eisold S; Linnebacher M; Ryschich E; Antolovic D; Hinz U; Klar E; Schmidt J
    World J Gastroenterol; 2004 Dec; 10(24):3583-9. PubMed ID: 15534911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the extracellular matrix proteins in the resistance of SP6.5 uveal melanoma cells toward cisplatin.
    Bérubé M; Talbot M; Collin C; Paquet-Bouchard C; Germain L; Guérin SL; Petitclerc E
    Int J Oncol; 2005 Feb; 26(2):405-13. PubMed ID: 15645125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The JAK/STAT pathway is involved in the upregulation of PD-L1 expression in pancreatic cancer cell lines.
    Doi T; Ishikawa T; Okayama T; Oka K; Mizushima K; Yasuda T; Sakamoto N; Katada K; Kamada K; Uchiyama K; Handa O; Takagi T; Naito Y; Itoh Y
    Oncol Rep; 2017 Mar; 37(3):1545-1554. PubMed ID: 28112370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Basement membrane proteins play an important role in the invasive processes of human pancreatic cancer cells.
    Sawai H; Okada Y; Funahashi H; Takahashi H; Matsuo Y; Yasuda A; Ochi N; Takeyama H; Manabe T
    J Surg Res; 2008 Jan; 144(1):117-23. PubMed ID: 17688882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of multidrug resistance by gefitinib via RAF1/ERK pathway in pancreatic cancer cell line.
    Xiao Z; Ding N; Xiao G; Wang S; Wu Y; Tang L
    Anat Rec (Hoboken); 2012 Dec; 295(12):2122-8. PubMed ID: 22907845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.